Discover
GOSS
Gossamer Bio, Inc.
0.17
4 x 0.16
2 x 0.16
bid
ask
+
0.00
1.88%
3 @ 06:32 AM
0.17 +0.01 (4.00%)
| Ytd | -94.59% | |
| 1y | -86.58% |
0.16
day range
0.17
0.14
52 week range
3.87
| Open | 0.17 | Prev Close | 0.16 | Low | 0.16 | High | 0.17 | Mkt Cap | 81.98M |
| Vol | 11.30M | Avg Vol | 11.93M | EPS | -0.79 | P/E | N/A | Forward P/E | -1.24 |
| Beta | 1.96 | Short Ratio | 6.29 | Inst. Own | 77.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 0.25 | 200-d Avg | 1.66 | 1yr Est | 7.61 |
GOSS News
businesswire.com
Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured F
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (NASDAQ: GOSS) (the “Company” or “Gossamer”), a bioph
benzinga.com
HC Wainwright & Co. Maintains Buy on Gossamer Bio, Lowers Price Target to $2
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a B
benzinga.com
Gossamer Bio Completes Debt Exchange, Converting $181M Of 2027 Notes Into New Secured Notes And Equi
Gossamer Bio, Inc. (NASDAQ:GOSS) (the "Company" or "Gossamer"), a biopharmaceutical